Quantitative EEG During Anesthesia Emergence in Children (qEEG)

September 2, 2019 updated by: Eugene Kim, Daegu Catholic University Medical Center

Quantitative Frontal Electroencephalography (EEG) and Postoperative Emergence Delirium Following General Anesthesia in Children: a Prospective Observational Study

Most drugs used in general anesthesia work on various receptors in the human brain, causing unconsciousness, loss of memory, and loss of reflection of the autonomic nervous system. After the anesthesia, baseline physiological function will be attained by administration of some reversal drugs or as the time goes by. In this process, various side effects may occur.

Emergence delirium (ED) is a representative behavioral disturbance after general anesthesia in children and that can cause several problems during the recovery period. Previous EEG studies reported that this phenomenon is related to hyperexcitation of the brain, and occurrence of epileptiform discharges during anesthesia induction may indicate an increased vulnerability for the development of a functional brain disorder in these children.

However, to the best of our knowledge, there is no studies concern evaluating quantitative EEG parameters for prediction of this postoperative negative behavior in children.

Study Overview

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 10 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This study collects subjects from a tertiary university hospital.

Description

Inclusion Criteria:

  • Children aged between 2 and 10 years of American Society of Anesthesiologists physical status (ASA PS) I or II who are planned to receive surgery under general anesthesia

Exclusion Criteria:

  • If the guardian and the subject are difficult to evaluate normally due to language barriers/language disorders/delay or autistic disorder
  • with developmental delay, neurological disorders or psychiatric diseases associated with symptoms of agitation, anxiety, attention deficit, sleep disturbances, etc
  • refusal of consent
  • Recent history (within a month) of received general anesthesia or surgery
  • presence of congenital or other genetic conditions thought to influence brain development

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurrence of Emergence delirium
Time Frame: During 60 minutes after PACU admission

On arrival at post-anesthesia care unit (PACU), patients are checked post-anesthesia emergence delirium (PAED). The PAED scale is a validated observational measure of 5 aspects of child behavior (caregiver eye contact, purposeful movement, evidence of awareness of surroundings, restlessness, and inconsolability). Ratings are summed to produce a total score ranging from 0 to 20; greater scores indicate greater severity.

If the PAED score is greater than 12, investigators define emergence delirium.

During 60 minutes after PACU admission
Relative power of each brain waves
Time Frame: From the cessation of sevoflurane inhalation to the extubation of airway devices such as tracheal tubes or laryngeal mask airway

Original frontal EEG segments are attained via 2 channel bispectral index monitoring (BIS VISTA™, Aspect Medical Systems, Inc. MA, USA) during the anesthesia period. The EEG is then segmented into 4 s epochs and fast Fourier transform (FFT) analysis is performed for each of these segments. FFT of all these selected EEG segments are computed in the following frequency bands:

Delta: 1-4 Hz Theta: 4-8 Hz Alpha: 8-13 Hz Beta: 13-30 Hz

And then, the relative power of each frequency bands to the total power of the sum is calculated.

From the cessation of sevoflurane inhalation to the extubation of airway devices such as tracheal tubes or laryngeal mask airway

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
modified Yale preoperative anxiety score (mYPAS)
Time Frame: before anesthesia induction (about 30 min before the surgery)
mYPAS is the assessment tool for measure the anxiety before induction. Higher score indicates higher anxiety.
before anesthesia induction (about 30 min before the surgery)
PAED score during PACU stay
Time Frame: During 60 min after PACU admission
On arrival at post-anesthesia care unit (PACU) and every 10 min from then, patients were checked PAED. The PAED scale is a validated observational measure of 5 aspects of child behavior (caregiver eye contact, purposeful movement, evidence of awareness of surroundings, restlessness, and inconsolability). Ratings are summed to produce a total score ranging from 0 to 20; greater scores indicate greater severity.
During 60 min after PACU admission
FLACC score on initial, 10, 20, and 30 min
Time Frame: During 60 minutes after PACU admission]
Face, legs, activity, cry, and consolability (FLACC) score is checked every 10min after PACU admission
During 60 minutes after PACU admission]
Watcha scale on initial, 10, 20, and 30 min
Time Frame: During 60 minutes after PACU admission

On arrival and 10, 20, and 30 min after PACU admission, patients were checked Watcha scale as following 4-point scale

  1. calm
  2. crying, but can be consoled
  3. Crying, cannot be consoled
  4. Agitated and thrashing around

Higher score indicates higher agitation.

During 60 minutes after PACU admission
Delta-theta to alpha-beta ratio (DTABR)
Time Frame: From the cessation of sevoflurane inhalation to the extubation of airway devices such as tracheal tubes or laryngeal mask airway

From the relative power of each brain waves, the investigators calculated the ratio as follows:

DTABR = (Delta wave + Theta wave)/(alpha wave + beta wave)

From the cessation of sevoflurane inhalation to the extubation of airway devices such as tracheal tubes or laryngeal mask airway
Delta to alpha ratio
Time Frame: From the cessation of sevoflurane inhalation to the extubation of airway devices such as tracheal tubes or laryngeal mask airway

From the relative power of each brain waves, the investigators calculated the ratio as follows:

DAR = Delta wave / alpha wave

From the cessation of sevoflurane inhalation to the extubation of airway devices such as tracheal tubes or laryngeal mask airway
Theta to beta ratio (TBR)
Time Frame: From the cessation of sevoflurane inhalation to the extubation of airway devices such as tracheal tubes or laryngeal mask airway

From the relative power of each brain waves, the investigators calculated the ratio as follows:

TBR = Theta wave / beta wave

From the cessation of sevoflurane inhalation to the extubation of airway devices such as tracheal tubes or laryngeal mask airway

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 8, 2019

Primary Completion (ACTUAL)

May 29, 2019

Study Completion (ACTUAL)

June 1, 2019

Study Registration Dates

First Submitted

January 5, 2019

First Submitted That Met QC Criteria

January 5, 2019

First Posted (ACTUAL)

January 9, 2019

Study Record Updates

Last Update Posted (ACTUAL)

September 4, 2019

Last Update Submitted That Met QC Criteria

September 2, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • DCMC#7

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia, General

3
Subscribe